Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07352566 · ClinicalTrials.gov registry record · Phase 4
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
A Phase 4 study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT07352566 is a Phase 4 study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 10 participants.
The verdict
NCT07352566, a Phase 4 study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
This study is being done to test a microdevice, which is a small device designed to test drugs directly on skin conditions like atopic dermatitis (eczema) and psoriasis. The small device, about the size of a grain of rice, has up to 20 tiny reservoirs that hold medications that are approved by the Food and Drug Administration (FDA) for atopic dermatitis and psoriasis. Very small amounts of these medications will be released into the skin (at levels in your body much lower than are typically used). In this study, the device will be tested to see if it's safe and works well for predicting how the skin will react to standard treatments. We will also look at how these reactions are connected to genetic information and overall treatment results.
Interventions
- DRUG 5-Fluorouracil
- DRUG Tapinarof
- DRUG Calcipotriene
- DRUG Triamcinolone
- DEVICE In situ cutaneous microdevice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-08-01 |
| Est. Completion | 2030-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07352566
The ClinicalTrials.gov registry entry for NCT07352566 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which 5-Fluorouracil is the first listed.
NCT07352566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07352566 about?
NCT07352566 is a clinical study titled "Utilization of a Microdevice for Psoriasis and Atopic Dermatitis". This study is being done to test a microdevice, which is a small device designed to test drugs directly on skin conditions like atopic dermatitis (eczema) and psoriasis. The small device, about the size of a grain of rice, has up to 20 tiny reservoirs that hold medications that are approved by the ...
What is the current status of trial NCT07352566?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2026-08-01. Estimated completion is 2030-06-01.
What interventions are being tested in trial NCT07352566?
The interventions under investigation include: 5-Fluorouracil (DRUG), Tapinarof (DRUG), Calcipotriene (DRUG), Triamcinolone (DRUG), In situ cutaneous microdevice (DEVICE).
Who is sponsoring clinical trial NCT07352566?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.